Delivery Order 75D30124D20079-75D30126F00004
Award Date 5/3/26
Potential Completion Date 4/14/28
Potential Value $3.2M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02210, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Ginkgo Bioworks, Inc., a Boston-based biotechnology company specializing in cellular engineering and genomic surveillance, was awarded a $50.2 million delivery order on September 6, 2024, under the CDC's Test Surge and Data Sharing multiple-award IDIQ contract. This firm fixed-price delivery order (Task Order 0001) extends through September 5, 2029, and represents the second task order issued under the parent IDIQ vehicle, which carries a total ceiling value of $118 million. The work will be...
- This federal contract award is for a delivery order under the "Test Surge and Data Sharing Multiple Award IDIQ" issued by the Centers for Disease Control and Prevention (CDC). The prime contractor is Ginkgo Bioworks, Inc., a biotechnology company based in Boston, Massachusetts. The contract has a ceiling value of $449,761.53 and a completion date of May 15, 2025. It is a time and materials contract type, with no set-aside designation. The contract leverages Ginkgo Bioworks' expertise...
- The Centers for Disease Control and Prevention (CDC) awarded a definitive firm fixed-price contract valued at $85.7 million to Ginkgo Bioworks, Inc., a Boston-based biotechnology company specializing in cellular engineering and genomic surveillance. The contract, awarded on February 28, 2025, supports the Traveler-Based Genomic Surveillance Program, with performance centered in Boston, MA and an ultimate completion date of March 21, 2028. This engagement represents a continuation of the...
- This is a $1,205,149.24 Firm Fixed Price contract awarded by the Centers for Disease Control and Prevention (CDC) to Ginkgo Bioworks, Inc., a biotechnology company based in Boston, Massachusetts. The contract, titled "TRAVELER-BASED GENOMIC SURVEILLANCE," is for the provision of biotechnology services to support the CDC's public health monitoring and emergency response initiatives. The contract has an ultimate completion date of September 19, 2024 and was awarded on August 26, 2024....
- This federal contract award is for an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the Centers for Disease Control and Prevention (CDC) for "Test Surge and Data Sharing" services. The $118 million IDIQ was awarded to Ginkgo Bioworks, Inc., a biotechnology company based in Boston, Massachusetts, on September 27, 2024. The contract has an ultimate completion date of September 5, 2029. This IDIQ is not designated as a set-aside contract. The IDIQ contract leverages...
- This firm-fixed-price contract was awarded by the Centers for Disease Control and Prevention (CDC) to Ginkgo Bioworks, Inc., a Boston-based biotechnology company, for "Airport Genomic Testing". The contract, valued at $76,575,638.04, requires Ginkgo Bioworks to collect a minimum of 483,000 biological samples per year from international travelers at five major U.S. airports, perform on-site reverse transcription polymerase chain reaction testing, whole genome sequencing, and collect and...
- The CDC Pittsburgh issued a $2.57 million delivery order to Laboratory Corporation of America on May 3, 2026, for metagenomic next-generation sequencing services under the Test Surge and Data Sharing parent IDIQ. Place of performance is Burlington, NC. The order carries a firm fixed price and an ultimate completion date of April 14, 2028. Work scope includes next-generation sequencing analysis and related diagnostic testing capabilities in support of CDC laboratory and epidemiological...
- The CDC Pittsburgh issued a $2,943,662.80 delivery order to Arup Laboratories Inc. on May 3, 2026, for metagenomic next-generation sequencing (MNGS) services under the Test Surge and Data Sharing multiple-award IDIQ. The Test Surge and Data Sharing IDIQ, administered by the Centers for Disease Control and Prevention, supports diagnostic testing and data sharing services across federal agencies. Place of performance is Emigration Canyon, UT. The order carries a firm fixed price and an ultimate...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $19,502 purchase order to Illumina, Inc. for ISEQ 100NGS kits. The firm fixed price contract has a period of performance of one day, September 6, 2023. The place of performance will be Illumina's location in Atlanta, Georgia. The CDC is likely procuring the next generation sequencing kits to support genomic surveillance efforts within its broader infectious disease programs. No...
- The Centers for Disease Control and Prevention (CDC) awarded a $176,623.68 firm fixed price purchase order to Illumina, Inc. for MISEQ REAGENT KITS V3 (600 CYCLE) to be delivered to their Pittsburgh location. The place of performance for this contract is in San Diego, California. The contract period of performance is from September 11, 2023 through November 2, 2023. No subcontractors or set aside designations were identified. The CDC works to protect public health and safety through the...